Physician profile
William C Kuo
NPI 1760487706
$8,670.09
in general payments reported to CMS, 2019-2025
22 companies · $1,418 in 2025
The $1,418 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.88 · 2020: $1,457 · 2021: $355 · 2022: $1,911 · 2023: $634 · 2024: $2,802 · 2025: $1,418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,749 · Travel and Lodging: $1,933 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,748.62 |
| Travel and Lodging | $1,933.04 |
| Education | $172.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,036.67 | 2023-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,749.75 | 2022-2025 | Interstim |
| Neotract INC. | $1,082.59 | 2020 | |
| Procept Biorobotics Corporation | $1,001.38 | 2022-2025 | Aquabeam System |
| Teleflex LLC | $914.35 | 2021-2025 | Urolift |
| Astellas Pharma US INC | $476.91 | 2020-2025 | Padcev |
| Valencia Technologies Corporation | $209.67 | 2024-2025 | Ecoin Device Kit |
| Femselect INC. | $206.67 | 2023-2025 | Enplace |
| Coloplast Corp | $184.22 | 2020 | |
| Dendreon Pharmaceuticals LLC | $141.07 | 2024 | Provenge |
| Abbvie INC. | $119.26 | 2024-2025 | |
| Intuitive Surgical, INC. | $101.87 | 2019-2024 | |
| Myriad Genetic Laboratories, INC. | $90.75 | 2023 | Prolaris |
| Myovant Sciences INC. | $78.78 | 2021 | |
| 180 Medical, INC. | $72.77 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $66.38 | 2019 | |
| Boston Scientific Corporation | $30.92 | 2021-2025 | Spaceoar Vue System - 10ml |
| Urogen Pharma, INC. | $26.34 | 2025 | |
| Sumitomo Pharma America, INC. | $24.91 | 2025 | Gemtesa |
| Ethicon US, LLC | $24.45 | 2024 | Enseal |
| Bayer Healthcare Pharmaceuticals INC. | $16.07 | 2021 | |
| Allergan, INC. | $14.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kuo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.